ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC11103-5mg |
|
1012343-93-9 |
IRAK inhibitor 3
|
0 | C21H21N5O4S | |
GC11102-500μg |
|
175735-93-0 |
α-Conotoxin MII
|
0 | C67H103N23O22S4 | |
GC11101-10mM (in 1mL DMSO) |
|
865479-71-6 |
5-R-Rivaroxaban
|
0 | C19H18ClN3O5S | |
GC11101-100mg |
|
865479-71-6 |
5-R-Rivaroxaban
|
0 | C19H18ClN3O5S | |
GC11101-50mg |
|
865479-71-6 |
5-R-Rivaroxaban
|
0 | C19H18ClN3O5S | |
GC11101-10mg |
|
865479-71-6 |
5-R-Rivaroxaban
|
0 | C19H18ClN3O5S | |
GC11100-50mg |
|
167933-07-5 |
Flibanserin
|
0 | C20H21F3N4O | |
GC11100-25mg |
|
167933-07-5 |
Flibanserin
|
0 | C20H21F3N4O | |
GC11100-10mg |
|
167933-07-5 |
Flibanserin
|
0 | C20H21F3N4O | |
GC11100-5mg |
|
167933-07-5 |
Flibanserin
|
0 | C20H21F3N4O | |
GC11099-10mM (in 1mL DMSO) |
|
3094-09-5 |
Doxifluridine
|
0 | C9H11FN2O5 | |
GC11099-5g |
|
3094-09-5 |
Doxifluridine
|
0 | C9H11FN2O5 | |
GC11099-1g |
|
3094-09-5 |
Doxifluridine
|
0 | C9H11FN2O5 | |
GC11098-1g |
|
1286770-55-5 |
Verubecestat (MK-8931)
|
0 | C19H18F5N5O5S | |
GC11098-500mg |
|
1286770-55-5 |
Verubecestat (MK-8931)
|
0 | C19H18F5N5O5S | |
GC11098-100mg |
|
1286770-55-5 |
Verubecestat (MK-8931)
|
0 | C19H18F5N5O5S | |
GC11098-25mg |
|
1286770-55-5 |
Verubecestat (MK-8931)
|
0 | C19H18F5N5O5S | |
GC11098-5mg |
|
1286770-55-5 |
Verubecestat (MK-8931)
|
0 | C19H18F5N5O5S | |
GC11097-50mg |
|
23007-85-4 |
MPTP hydrochloride
|
0 | C12H16ClN | |
GC11097-10mg |
|
23007-85-4 |
MPTP hydrochloride
|
0 | C12H16ClN | |